GSH augmentation deserves investigation as a beneficial therapeutic approach for not only PD but also numerous other CNS disorders for which GSH deficiency and GSH-related enzyme deficits have been documented (multiple sclerosis, 25,26 autism, 2729 Alzheimers disease, 30,31 schizophrenia, 32,33 and bipolar disease 34 )
R., Stokes, D
These include B1, B2, B3, B5, B6, B7, B9, and B12
Patients should always consult qualified healthcare professionals regarding peptide therapy options, treatment plans, and safety considerations
Park YC, Kim J, Seo MS, Hong SW, Cho ES, Kim JK
Intranasal administration of brain-derived neurotrophic factor rescues depressive-like phenotypes in chronic unpredictable mild stress mice